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Abstract  
Background: Besides the continuous increase in the prevalence of diabetes mellitus, visual 
impairment has become a prevailing public health problem in diabetic patients, especially in 
developing countries. Evidences are limited on the prevalence and associated factors of visual 
impairment among diabetic patients in Ethiopia.  
Objective: The aim of this study was to assess the prevalence and associated factors of visual 
impairment among diabetic patients at Debre Berhan referral hospital. 
Methods and materials: A hospital based cross sectional study was carried out from April 27 
to May 19, 2017. All adults with diabetes mellitus at Debre Berhan referral hospital were 
included in the study. Pre tested and semi structured questionnaire and ocular examinations 
were used to collect data. Data were entered into Epi Info 7 and exported to Statistical package 
for social sciences version 20 for analysis. The descriptive analysis was summarized by 
frequency, percent and summary statistics. Variables with p-value < 0.2 in bivariable binary 
logistic regression, were fitted to multivariable logistic regression. P-values of less than 0.05 
were set to declare statistical significance. Adjusted odds ratio and 95% CI were used to 
determine the strength of association. Hosmer and Lemeshow goodness of fit was used to 
check for model fitness. 
Result: A total of 388 study subjects participated in the study. The response rate was 92%. 
The median age of study participants was 45 years [IQR 30-56]. The prevalence of visual 
impairment was 29.38% (95% CI: 24.83%-33.93%). Age >56 years (AOR=9.7, 95% CI: 3.1-
30.1), 46-56 years (AOR=3.2, 95% CI: 1.1-8.7), physical inactivity (AOR=2.1, 95% CI: 1.2 -3.7), 
history of eye examination (AOR=1.9, 95% CI: 1.05-3.4), lower body mass index (AOR=6.2, 
95% CI: 2.1-18.9) and  presence of visual symptoms (AOR=4.1, 95% CI: 2.2-7.6) had 
statistically significant association with visual impairment.  
Conclusion and recommendation: About one third of diabetic patients had visual 
impairment. Diabetic patients are recommended to normalize their body mass index and have 
regular physical exercises.   
Keywords: Diabetes mellitus, Ethiopia, Prevalence, Visual impairment
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1 Introduction 
1.1 Statement of the problem 
Visual impairment is defined as presenting visual acuity of less than 6/18 in either 
eye (1).  
Visual impairment is a significant public health issue in diabetic patients, particularly 
in developing countries (2). More than ten percent of diabetic patients develop visual 
impairment within 15 years of diagnosis (3). Diabetes mellitus (DM) is one of the top 
and most preventable cause of new cases of blindness in adults aged 20–74 years 
in the United States (4, 5). Visual impairment is highly prevalent in diabetic patients. 
Several studies done in Africa and other parts of the world has shown that the 
prevalence of visual impairment among diabetic patients were between 16.7% and 
55% and some factors associated with visual impairment were reported (6-12).  
Visual impairment can result in loss of productivity and dependency. In addition, the 
frequent health service use by diabetic patients makes diabetes mellitus more 
expensive disease that can pose large economic challenges on diabetic patients 
themselves, their families and countries and national health systems at large. Many 
countries spend between 5% and 20% of their total health expenditure on diabetes 
(13). 
Despite this economic challenges, the prevalence of DM is progressively increasing 
from time to time  which in turn increases the number of visual impairment among 
diabetic patients (6, 13). Evidence based actions are required to prevent and avoid 
visual impairment in diabetic patients (6) 
However, evidences are limited on the prevalence and associated factors of visual 
impairment among diabetic patients in Ethiopia. 
Diabetic eye disease is among the priorities of vision 2020 “the right to sight’’, to 
eliminate avoidable blindness from the world by the year 2020, in which Ethiopia is a 
member state. Because of lacking evidences, it is difficult to speak about the 
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progress of the visual impairment. Providing information on the magnitude as well as 
factors associated with visual impairment in diabetic patients may be helpful to 
advocate for greater political and financial commitment and for proper allocation of 
resources, so that effective delivery of eye care services is possible  for diabetic 
patients in avoiding avoidable visual impairment (6, 14). It also helps as a baseline 
for monitoring, follow-up and evaluation of programs.  
Therefore the aim of this study was to estimate the prevalence of visual impairment 
and associated factors among diabetic patients. 
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1.2 Literature review 
1.2.1 Prevalence of visual impairment in diabetic patients 
Visual impairment in diabetic patients is high. Several studies done in different parts 
of the world showed that the prevalence of visual impairment among diabetic 
patients was between 16.7% and 55% (4, 6-12). 
In the United States, DM is the principal cause of new cases of blindness among 
adults aged 20–74 years (4). Around 4.2 million (28.5%) people had diabetic 
retinopathy between the year 2005 and 2008 among diabetics aged 40 years or 
older, that may have resulted some sort of vision loss (4). It has been reported in 
2002 by the Centers for disease control and prevention (CDC) that the prevalence of 
visual impairment among diabetics ≥18 years old was 23.5% (11).  
A cross sectional survey of type 2 diabetes in China, Xinjing town in 2015 has 
shown that  8.5% of the eyes had moderate or severe visual impairment and 3.7% 
of the eyes were blind with best possible correction (8). In a multi ethnic Asian study 
in Singapore the prevalence of bilateral blindness was 1.5% and bilateral visual 
impairment was 26.8% (15). 
Cross sectional studies conducted in Africa has revealed different figures on the 
prevalence of visual impairment among diabetics. The prevalence of visual 
impairment among diabetics was 44.9% in a South Africa in 2014 (16), 22.2% in a 
Tunisia in 2014 (7), 16.7% in Nigeria (Maiduguri Teaching Hospital) in 2012 (17), 
and 22.6% in Cameroon in 2014 (9).   
A retrospective observational study of diabetic patients done in 2011 in Yemen, 
showed the prevalence of visual impairment and blindness to be 39.3% and 15.7% 
respectively (12). 
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The Ugandan hospital based cross sectional study on diabetic patients who were 18 
years old and above revealed that the prevalence of visual impairment to be 28.6% 
(18).  
In Ethiopia, evidences  regarding the prevalence of visual impairment among 
diabetic patients were not found. 
1.2.2 Factors associated with visual impairment in diabetic patients 
Factors associated with visual impairment among people with DM were identified in 
different studies. However, the factors varied across studies (7-9, 12, 15, 16, 18). 
Older age is the most consistently associated factor with visual impairment in people 
among diabetes mellitus in most studies (7, 8, 12, 15, 16, 18) 
In a cross sectional survey done on type 2 diabetes mellitus patients in china, Xinjing 
town, in 2016: female gender and earlier onset of diabetes were positively 
associated with visual impairment (visual acuity < 20/63 in the better eye) (8).  
In a multi-ethnic Asian study done in 2012 in Singapore; male gender, lower body 
mass index (BMI) and longer duration of DM were positively associated with bilateral 
visual impairment (15). 
In a cross sectional study in  South Africa, 2014 (16) monthly income were 
significantly associated with visual impairment, whereas in Tunisia, 2014 (7) 
duration of DM >10 years, obesity and high blood pressure were positively 
associated with visual impairment. Physical activity was negatively associated with 
visual impairment in the South African (16) study. 
Severely impaired vision <6/60 had positive association with duration of DM ≥10 
years, and hypertension in a cross sectional  study in Cameroon, 2015 (9). 
In Yemen, male gender, mode of treatment (ocular hypoglycemic agents and diet), 
duration of DM (5-9 years) were positively associated with presence of visual 
impairment (12). 
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Age >59 years and history of visual complaint on presentation were positively 
associated with visual impairment in Ugandan in 2016 (18).  
The factors associated with visual impairment related with DM are undetermined in 
Ethiopia. 
1.2.3 CONCEPTUAL FRAMEWORK 
The conceptual frame work was developed by reviewing different literatures (7-9, 12, 
15, 16, 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Conceptual Framework showing association of factors with visual 
impairment among adults with diabetes mellitus 
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1.3 Justification of the study 
Prevalence of visual impairment is high among diabetic patients according to studies 
done in Africa and different parts of the world. Evidence on prevalence and 
associated factors of visual impairment among Ethiopian diabetic patients were not 
found. In addition, the reported  prevalences of visual impairment among diabetic 
patients in Africa and other parts of the world have wide discrepancies. Determining 
the prevalence of visual impairment among diabetic patients may be helpful in 
proper allocation of resources.  
The factors  in Ethiopian diabetic patients may be different from other studies due to 
socio-cultural and economic variations. Identifying the factors could be useful to the 
health authorities in planning for the prevention and elimination of modifiable factors 
associated with visual impairment among people with DM.  
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2 Objectives  
2.1 General objective 
 To assess the prevalence and associated factors of visual 
impairment among adults with diabetes mellitus attending  
Debre Berhan referral hospital, North Shoa, Ethiopia, 2017. 
2.2 Specific objectives 
 To estimate the prevalence of visual impairment among diabetic 
patients at DBRH. 
 To identify factors associated with visual impairment among 
diabetic patients at DBRH.  
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3 Methods and materials 
3.1 Study design  
A hospital based cross sectional study was conducted. 
3.2 Study area and period  
The study was conducted at DBRH from April 27/2017 to May 19/2017. DBRH is 
found in North Shoa zone of Amhara National Regional State which is located 130 
km north of Addis Ababa, the capital city of Ethiopia. It is the only referral hospital 
and the only eye center in North Shoa zone and has a catchment of approximately 
2.8 million people according to the data obtained from DBRH health information 
department. It mainly receives patients from North Shoa zone of Amhara region and 
partly from Oromia and Afar regions. General practitioners, Internists and nurses 
were involved in the clinical service of diabetic patients.  
3.1 Source  population/study population 
All adults aged ≥ 18 years with DM, attending DBRH.  
3.1.1 Inclusion criteria 
All adults with diabetes mellitus aged ≥ 18 years, attending DBRH. 
3.2 Sample size determination  
Previous evidences on the prevalence and associated factors of visual impairment 
among diabetic patients in Ethiopia were not found. Therefore, 50% was used as the 
hypothesized proportion of visual impairment among diabetic patients to calculate 
the sample size. Single proportion formula was used to determine the sample size.  
  =
     ⁄  
 
 (1 −  )
  
 
Where; n – sample size,   
Z is Value of z statistic at 95% confidence interval = 1.96 
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 P – Hypothesized proportion of visual impairment in diabetic  patients in 
Ethiopia =  50%. 
 1-P = 1-0.50 = 0.50  
 d – Maximum allowable error (marginal error) 5% = 0.05 
 sample size( ) =
( .  )  .  (   .  )
 .   
= 384 
With 10% non response rate,  the final sample size was 422. 
3.3 Sampling  
All consecutive adults aged ≥18 years with DM during the data collection period and 
who consented to participate were included in the study. 
3.4 Variables of the study 
3.4.1 Dependent variable 
Visual impairment among diabetic patients 
3.4.2 Independent variables 
Socio-demographic factors: Age, Sex, Religion, Ethnicity, Residence, Marital 
status, Education level, Occupation and Monthly income 
Clinical variables: Body mass index, Type of DM, Duration of  DM since diagnosis, 
Fasting Blood sugar level, Mode of treatment  History of eye examination and Visual 
symptoms 
Systemic co-morbidities: Hypertension and HIV status 
Behavioral factors: Physical activity and Alcohol consumption 
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3.5 Operational definitions 
Visual impairment  
Visual impairment was defined as presenting visual acuity worse than 6/18 (<6/18 - 
NLP). Visual impairment was further categorized in to moderate visual impairment  
(PVA < 6/18 - 6/60), sever visual impairment (PVA < 6/60 - 3/60), blindness (PVA  < 
3/60 - NLP), monocular moderate visual impairment (presenting distance VA of 
<6/18 - 6/60 in one eye and 6/6 - 6/18 in the other eye), monocular severe visual 
impairment (PVA < 6/60 - 3/60 in one eye and 6/6 - 6/60 in the other eye) and 
monocular blindness ( PVA  < 3/60 - NLP in one eye and PVA of 6/6 - 3/60 in the 
other eye) (1).  
Body Mass Index (BMI) 
BMI (kg/m2 ) was calculated as weight (kg) divided by height in square meters (m2) 
and was graded according to the WHO classification. A BMI of <18.5 was 
underweight, a BMI of 18.5- 24.9 kg/m2 was normal, a BMI of 25–29.9 kg/m2 was 
overweight and a BMI of ≥ 30 kg/m2  was obese (19). 
Alcohol consumption 
Those who drunk more than 4.67 units of drinks on any single day (around 2 pints of 
4% beer or 2 medium (175 milliliter) glasses of 13% wine) and  more than 14 units of 
drinks per week (6 pints of beer or 1.4 bottles of 13% wine) were considered as 
drinkers. Those who drunk lower than this level were considered as non drinkers 
(20). 
Physical exercise: people who performed at least 75 minutes of aerobic physical 
activity throughout the week like running, bicycling, jumping rope, and swimming 
were considered as engaged in physical activity, but those who performed less than 
this were not considered as engaged in physical activity (21).  
History of eye examination: people who had been examined their eyes after the 
diagnosis of DM and before the data collection time were considered as examined 
and people who was not examined were considered not examined. 
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Visual symptoms: people who had symptoms like blurring of vision, flashing of 
light, floaters, halos or visual field loss at the time of data collection were considered 
as symptomatic. Those who hadn't visual symptoms were considered as 
asymptomatic. 
Fasting blood sugar: FBS level of >126mg/dl was considered as hyperglycemia 
and <126mg/dl was normal (22).  
Urban: the presence of infrastructures like paved streets, electric lighting, sewage or 
based on economic functions where the majority of the population is not primarily 
engaged in agriculture, or where there is surplus employment (23). Population not 
classified as urban constitute rural.  
3.6 Data collection procedures and personnel 
The Amharic version of pretested and structured interviewer administered 
questionnaire and ocular examinations were used to collect data. Snellen's E chart, 
pinhole disc, schiotz tonometer, pen torch, slit lamp biomicroscope, direct 
ophthalmoscope, Volk and binocular indirect ophthalmoscope were used for ocular 
examination. Digital balance was used for weight measurement and meter tape was 
used for height measurement. 
Three nurses, two Optometrists were involved in the data collection process. After 
getting the informed consent by the principal investigator at the chronic disease 
department, two nurses interviewed the study participants on the interview part of 
the questionnaire including demography, behavioral factors and systemic co-
morbidities. Regarding the clinical data, the nurses also interviewed the study 
participants about duration of DM, mode of treatment and presence of visual 
symptoms, took measurements on weight and height, and referred patients' folder to 
note on the type of DM and FBS level. The patients' folder was marked after relevant 
data were collected to avoid repeated collection of data on the same patient. The 
patient was then sent to Ophthalmology department to undergo ocular examinations. 
The vision was measured by the third nurse and the IOP was measured by 
Optometrists. First distance presenting visual acuity was measured using Snellen’s 
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E chart at 6 meters. When the patients' presenting distance VA was worse than 6/18 
a pinhole vision was checked to rule out refractive error. When the  vision was 
improved with pinhole, refractive error  was recorded in the ocular abnormalities list. 
The presenting visual acuity was recorded in a fraction notation. IOP was measured 
using schiotz tonometer and recorded in mmHg. 
Anterior and posterior segment examinations were done by two Optometrists in the 
Ophthalmology department. Anterior segment examination was done using pen 
torch and slit lamp biomicroscope for study participants and posterior segment 
examination was done using direct ophthalmoscope. Pupilary dilatation and 
funduscopy with 90D/78D Volk or binocular indirect ophthalmoscope was used to 
examine the posterior segment in cases where direct ophthalmoscopy was not 
adequate. When pupil dilation was needed, it was done using 1% tropicamide eye 
drop. At the end of ocular examination each patient was told about his/her vision 
status and eye conditions. Patients were linked to ophthalmology department for 
further treatment, follow up and/or referral when necessary.  
3.7 Data quality assurance 
After translating the English version of the questionnaire to Amharic, the Amharic 
version of the questionnaire was pre tested to assure for the appropriateness and 
translated back to English. 
All the data collectors (three Nurses, two Optometrists and one Ophthalmologist) 
were trained for one day about the data collection process. Unclear issues on data 
collection were solved by the primary investigator. Cronbach's alpha was used to 
check the reliability of the questionnaire. 
Each day during the data collection 5% of the data was cross checked for 
completeness by principal investigator.  
3.8 Data analysis 
After data was checked for completeness and consistency it was coded and entered 
in to EPI info 7 and exported to SPSS version 20 for analysis. The descriptive 
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statistics was summarized using summary statistics such as frequency tables, 
graphs, percentages, means, medians, quartiles and standard deviations. Binary 
logistic regression was used to identify factors associated with visual impairment. 
Variables with p-value < 0.2 in bivariable binary logistic regression, were fitted to 
multivariable logistic regression. P-values of less than 0.05 were set to declare 
statistical significance. Adjusted odds ratio and 95% CI were used to determine the 
strength of association. Hosmer and Lemeshow goodness of fit was used to check 
for model fitness. 
3.9 Ethical considerations 
Ethical clearance was obtained from University of Gondar, College of Medicine and 
Health Sciences, school of medicine ethical review committee. Permission was 
obtained from Debre Berhan referral hospital to conduct the data collection process.  
Informed consent was obtained from each study participants after explaining the 
purpose of the study. They were given full right to participate, refuse or with draw the 
study at any time they want. Confidentiality of the information obtained was assured 
by coding and locking the data.  
Diabetic patients with visual impairment and other ocular problems were linked to 
the ophthalmology department for treatment, follow up and/or referral. All study 
participants were advised about the importance of regular ocular screening even in 
the absence of any visual symptoms or problems.   
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4 Results 
4.1 Socio-demographic characteristics of study participants  
A total of 388 participants were included in this study. The response rate was 92%. 
The median age of study participants was 45 years [IQR 30-56]. Males were 208 
(53.6%) and 359 (92.5%) were Orthodox Christians. Most of study participant were 
urban residents 253 (65.2%) and Amhara  326 (84%) in ethnicity. The median 
monthly income was ETB 700 [IQR of 400-2000 ETB]. (see table 1) 
Table 1: Socio-demographic characteristics of diabetic patients at Debre 
Berhan referral hospital, Ethiopia, 2017 (n=388) 
Variable  Frequency  Percentage 
Age (years)   
18-30 109 28.1 
31-45 96 24.75 
46-56 87 22.4 
>56 96 24.75 
Sex   
Male 208 53.6 
Female 180 46.4 
Religion   
Orthodox 359 92.5 
Muslim  22 5.7 
Protestant 7 1.8 
Ethnicity   
Amhara 326 84.0 
Oromo 41 10.6 
Tigrie 4 1.0 
Guragie 17 4.4 
Marital status   
Currently single 134 34.5 
Currently married 254 65.5 
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n = sample size 
4.2 Clinical and behavioral characteristics of study participants 
Type 2 diabetic patients were 228 (58.8%).The median for duration of diabetes was 
3.5 years  [IQR 2- 6.75]. The minimum duration of diabetes after diagnosis was one 
day and the maximum was 28 years. The median for FBS was 147.5mg/dl [IQR 113- 
188.75]. About 364 (93.8%) of diabetic patients do not drink alcohol, 225 (58%) were 
engaged in physical activities and 200 (51.5%) had history of eye examination. (see 
table 2 below) 
Educational status 
Can't read and write 111 28.6 
Read and write only 71 18.4 
Primary school 49 12.6 
Secondary school 61 15.7 
College/University 96 24.7 
Occupation   
Employed 80 20.6 
Merchant 31 8.0 
Farmer 77 19.8 
House wife 86 22.2 
Retired 50 12.9 
Not employed 64 16.5 
Residence   
Urban 253 65.2 
Rural 135 34.8 
Monthly income   
<400 ETB 66 17.0 
400-699 ETB 104 26.8 
700-1999 ETB 115 29.6 
≥ 2000 ETB 103 26.6 
16 
 
Table 2: Clinical and behavioral characteristics of adults diabetic patients at 
Debre Berhan referral hospital, Ethiopia,  2017 (n=388) 
Variables Category  Frequency  Percentage 
BMI Under weight 25 6.4 
 Normal  260 67.0 
 Over weight 97 25.0 
 Obese 6 1.5 
Type of DM Type 1 160 41.2 
 Type 2 228 58.8 
Duration of DM (years) <5  232 59.8 
 [5-10) 99 25.5 
 [10-15) 33 8.5 
 15+ 24 6.2 
FBS level (mg/dl) Normal 139 35.8 
 Hyperglycemic  249 64.2 
Mode of treatment Tablets  169 43.6 
 Insulin injection 214 55.2 
Visual symptoms Symptomatic 204 52.6 
 Asymptomatic 184 47.4 
Alcohol consumption Yes 24 6.2 
 No 364 93.8 
Physical exercise Yes 225 58 
 No 163 42 
eye exam history Yes 200 51.5 
 No 188 48.5 
    
 4.3 Systemic co-morbidities of study participants
Systemic hypertension was
HIV positive. (See table 3 below)
Table 3: Systemic co-morbidities 
Berhan referral hospital, 
Variables Category 
HTN Yes
No 
HIV status          Negative 
Positive 
Not known
n = sample size 
4.4 Prevalence of visual impairment in diabetic patients
The prevalence of visual impairment among adults with diabetes mellitus was 
to be 29.38% (95% CI: 24.7
Figure 2: Pie chart showing prevalence of visual impairment among adults 
with diabetes mellitus attending D
Nearly half (49.1%) of the p
visual impairment category.
 
Visual 
impairment
(29.38%)
17 
 
 found in 95 (24.5%) of DM patients and 21 
 
of adults with diabetes mellitus at Debre 
Ethiopia, 2017 (n=388) 
 Frequency  Percentage 
 95 24.5
293 75.5
 328 84.5
 21 5.4
 39 10.1
 
%-34.3 %). (see fig 2 below) 
  
ebre Berhan referral hospital, Ethiopia
atients with visual impairment were in the moderate 
 (See table 4 below) 
No Visual 
impairment
(70.62%)
(5.4%) were 
 
 
 
 
 
 
found 
, 2017 
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Table 4: Frequencies of visual impairment categories among diabetics with 
visual impairment at Debre Berhan referral hospital, Ethiopia, 2017 
Visual impairment Category Frequency Percentage 
   
<6/18-6/60 Bilateral Moderate VI 56  49.1 
<6/60-3/60 Bilateral Sever VI 6 5.3 
<3/60-NLP Bilateral Blindness 6 5.3 
<6/18-6/60, other eye 6/6-6/18 Monocular Moderate VI  28 24.6 
<6/60-3/60, other eye 6/6 - 6/60 Monocular Sever VI 11 9.6 
<3/60-NLP, other eye 6/6- 3/60 Monocular Blindness 7 6.1 
Total 114 100.0 
   
The most common ocular abnormalities seen in diabetic patients with visual 
impairment attending DBRH was Cataract, Refractive error,  DR and Glaucoma. 
(See fig 3)  
 
          RE = Refractive error   DR= diabetic retinopathy 
Figure 3: Common ocular abnormalities found in diabetics with visual impairment at 
Debre Berhan referral hospital, Ethiopia, 2017 
39%
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4.5 Factors associated with visual impairment in diabetic patients 
From bivariable analysis Age,  occupation, residence, income, alcohol consumption, 
physical activity, presence of visual symptoms, type of DM, duration of DM, mode of 
treatment,  BMI, HIV status, hypertension and history of eye examination were 
selected and fitted to multivariable analysis. 
Using Enter method in multivariable analysis, variables that had statistically 
significant association with visual impairment in diabetic patients at Debre Berhan 
referral hospital were age, physical inactivity, history of eye examination, lower BMI 
and presence of visual symptoms. 
The odds of visual impairment in old age >56 years was nearly 10 times (AOR=9.7, 
95% CI: 3.1-30.1) than that of age 18-30 years, whereas diabetics aged 45-56 years 
were about 3 times (AOR=3.2, 95% CI: 1.1-8.7) to have visual impairment than 
age18-30 years. The odds of visual impairment in diabetics who were not engaged 
in physical exercise was 2 times (AOR=2.1, 95% CI: 1.2 -3.7) as compared to those 
who performed physical activities. The odds of visual impairment for people who had 
history of eye examination was about two times (AOR=1.9, 95% CI: 1.05-3.4) than 
those who hadn't. Underweight (lower BMI) diabetics were about six times 
(AOR=6.2, 95% CI: 2.1-18.9) likely to have visual impairment than normal weighted 
diabetic individuals. Visual impairment was about four (AOR=4.1, 95% CI 2.2-7.6) 
times in diabetic patients who had visual symptoms at the time of data collection 
than those hadn't. (see table 5 below) 
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Table 5: Factors associated with visual impairment among diabetic patients at 
Debre Berhan referral hospital, Ethiopia, 2017 
 
 
Variable  
Visual 
Impairment 
 
 
COR(95%CI) 
 
 
AOR(95%CI) Yes No 
Age (years)     
18-30 14 95 1 1 
31-45 13 83 1.06 (0.47-2.39) 1.32(0.49-3.5) 
46-56 27 60 3.05 (1.5-6.3) 3.2 (1.1-8.7 )* 
>56 60 36 11.3 (5.6-22.7) 9.7 (3.1-30.1)*** 
Sex     
Male 60 148 1  
Female 54 126 1.06 (0.68-1.64)  
Marital status     
Currently single 44 90 1.29 (0.82-2.02)  
Currently married 70 184 1  
Educational status     
Can't read and 
write 
38 73 1.4 (0.77-2.5)  
Read and write 
only 
20 51 
1.06 (0.5-2.1) 
 
Primary school 14 35 1.07 (0.5-2.32  
Secondary school 16 45 0.96 (0.5-1.9)  
College/University 26 70 1  
Occupation     
Employed 17 63 1 1 
Merchant 11 20 2.0 (0.8-5.1) 2.1 (0.7-6.3) 
Farmer 14 63 0.8 (0.37-1.8) 0.9 (0.3-2.7) 
House wife 27 59 1.7 (0.84-3.4) 0.88 (0.3-2.1) 
Retired 35 15 8.6 (3.8-19.4) 2.7 (0.9-7.5) 
Not employed 10 54 0.69 (0.3-1.6) 0.5 (0.2-1.6) 
Residence     
Urban 86 167 1.97 (1.2-3.21) 0.91 (0.34-2.33) 
Rural 28 107 1  
Monthly income     
<400 16 50 1.05 (0.5-2.2) 2.18 (0.58-8.26) 
400-699 34 70 1.6 (0.86-2.9) 3.85(1.36-10.87) 
700-1999 40 75 1.8 (0.96-3.2) 2.18 (0.83-5.70) 
>/=2000 24 79 1  
 
Alcohol  
    
Yes  
 
14 
 
10 
 
3.7 (1.6- 8.6) 
3.7 (0.85-7.85) 
No  100 264 1  
21 
 
Physical activity      
Yes  49 176 1  
No  65 98 2.4 (1.5-3.7)  2.1(1.2-3.7)** 
History of Eye exam     
Yes  84 116 3.8 (2.4-6.2) 1.9 (1.05-3.4)* 
No  30 158 1 1 
BMI     
Normal weight  63 197 1 1 
Underweight 10 15 2.1 (0.9-4.8) 6.2 (2.1-18.9)** 
Overweight & 
Obsess 
41 62 
2.1 (1.3-3.4) 0.9 (0.5-1.9) 
Type of DM     
Type 1 22 138 1  
Type 2 92 136 4.2 (2.5-7.15) 1.95 (0.65-5.83)  
Duration of DM since 
diagnosis 
    
[0-5) 55 177 1  
[5-10) 29 70 1.3 (0.78-2.3) 0.76 (0.38-1.55) 
[10-15) 14 19 2.4 (1.1-5.0) 0.44 (0.15-1.27) 
15+ 16 8 6.4 (2.6-15.8) 1.45 (0.42-4.92) 
Mode of treatment     
Tablets  67 107 2.2 (1.4-3.5) 0.5 (0.2-1.04) 
Injections  47 167 1 1 
Recent FBS     
Normal 42 97 1  
Hyperglycemia 72 177 0.94 (0.6-1.5)  
Visual Symptom     
Symptomatic  91 113 5.6 (3.36-9.4) 4.1 (2.2-7.6)*** 
Asymptomatic  23 161 1 1 
Hypertension     
Yes  51 44 4.2 (2.6-6.9) 1.27 (0.61-2.66) 
No  63 230 1  
HIV     
Negative  93 235 1  
Positive  11 10 2.7 (1.14-6.8) 2.21 (0.63-7.80) 
Don't know 10 29 0.87 (0.4-1.86) 0.93 (0.34-2.50) 
(n = sample size)  (* p value <0.05)   (**  p value <0.01)  (***  p value <0.001)  
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5 Discussion 
The prevalence of visual impairment among diabetic patients attending Debre 
Berhan referral hospital, North Shoa Ethiopia, was found to be 29.38% (95% CI: 
24.83%-33.93 %).  
This proportion of visual impairment was higher than those studies done in China 
(12.2%) (8), Tunisia (22.2%) (7), Nigeria (16.7%) (17) and Cameroon (22.6%) (9). 
The possible difference between this study from the Chinese and Tunisian studies 
may be due to differences in the definition of visual impairment. The Chinese study 
used the best corrected visual acuity to define visual impairment, unlike this study 
which used presenting visual acuity. Best corrected visual acuity underestimates the 
real burden of visual impairment. The Tunisian study used the better eye vision to 
say visual impairment. If a person's one eye is normal and the other is impaired,  this 
person will not be considered as visually impaired when the better eye definition is 
used. But in this study monocular visual impairment  was incorporated according to 
the ICD update and revision platform (1). The Nigerian and the Cameroonian study  
used a very small sample size, 84 and 96 respectively, which may be the reason for 
their small prevalence of visual impairment as compared to this study.  
However, the prevalence of visual impairment in this study was lower than studies 
done in South Africa (44.9%)  (16) and Yemen (55%) (12). The study  participants 
were diabetic patients aged 40 years and older in the South African study and aged 
18 years and above in this study. The relatively older study participants may be the 
reason for higher prevalence of visual impairment in the South  African study. It may 
also be due to differences in visual impairment definition. Visual acuity of <6/9.5 was 
grouped to visual impairment in the South African study as compared to this study 
which was VA of <6/18.  
 Socio-cultural variations may be responsible for the wide difference between the 
Yemeni and this study. Because of familial clustering and the high rate of 
consanguinity in the Yemeni population, which are genetic risk factors for early onset 
type 2 DM, higher diabetes mellitus complications are expected that may result in 
visual impairment (12, 24, 25). The Yemenis diabetic patients had longer duration of 
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diabetes than this study subjects. In the Yemeni study, 52% of study population had 
DM for more than 10 years whereas only less than 15% of study population had DM 
for more than 10 year in this study.  
The prevalence of visual impairment in this study was in line with a study done in 
Uganda (28.6%) (18). This may be due to similarities in ages of study participants 
(≥18years), use of presenting visual acuity and the cut off point for visual impairment 
(VA <6/18). 
In this study, older age was positively associated with visual impairment which was 
consistent with other studies done in China(8), Singapore (15), South Africa(16), 
Tunisia (7), Yemen (12) and Uganda(18). The possible reason for increased visual 
impairment in old age may be due to, increased age related eye diseases with old 
age and because of long duration of DM with older age, that may result in diabetic 
complications in the eyes.  
Physical inactivity was positively associated with visual impairment which was in line 
with the South African study. The reason for this may be due to the poor control of 
diabetes in people who were not engaged in physical activities.  
History of eye examination was positively associated with visual impairment in 
diabetic patients in this study. The reason for this may be because of the fact that 
people with visual impairment are more likely to be examined their eyes than those 
without visual impairment. Even if they were examined, visual impairing conditions 
may have not be treated for different reasons like waiting the cataract till it matures 
or due to financial problems. Ocular conditions like DR, Glaucoma and AMD can 
cause visual impairment that cannot be avoided.  
Presence of visual symptoms were also positively associated with visual impairment 
in this study which was in line with the Ugandan study. Visual impairment is most 
likely to have symptoms like blurring of vision. So the positive association of visual 
impairment and visual symptoms is likely.  
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Patients with lower BMI in this study were positively associated with visual 
impairment which was in agreement with a multi-ethnic Asian study. But in the 
Tunisians study, it was BMI >25 (overweight) that had statistically significant 
association. This may be because the majority (89%) of Tunisian study subjects 
were type 2 diabetics as compared to our study participants which were only 58.8%. 
Overweight individuals are more likely to be Type 2 diabetics (13).  
However, factors like sex, monthly income , duration of DM, hypertension were not 
associated with visual impairment in our study which were previously reported to 
have association with visual impairment in other studies (6-9, 12, 15, 18). In this 
study, the duration of diabetes mellitus is shorter than those of the Yemeni study 
participants. In the Yemenis study, 52% of their study participants had DM for more 
than 10 years whereas less than 15% had More than 10 year in this study. 
Moreover, the duration was as high as 49 years in Yemenis diabetic patients which 
is much higher than our diabetic patients which was 28 years. This may be the 
reason that duration is associated in their study but not in this study. 
5.1 Limitations of the study 
Visual impairment was not was defined in terms of visual field because of feasibility 
issues. Since the study was cross sectional no follow ups were done and  
fluctuations of vision with fluctuations blood sugar level was not considered. The 
study was conducted at a single center.  
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6 Conclusion 
About one third of diabetic patients had visual impairment. Older age, physical 
inactivity, history of eye examination, presence of visual symptoms and lower BMI 
were significantly associated with visual impairment in diabetic patients. 
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7 Recommendations  
It is recommended for DBRH (Ophthalmology department) to: 
Provide affordable eye care services for diabetic patients with visual impairment to 
avoid visual impairment. 
It is recommended for DBRH chronic disease department to: 
Advice diabetic patients to normalize their BMI and have regular physical activities. 
It is recommended for researchers to:     
Conduct further studies on visual impairment among diabetic patients by involving 
larger study population and multi centers. 
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Annexes 
Annex 1 Information Sheet 
Title of the research project – Prevalence and associated factors of visual 
impairment among diabetic patients attending Debre Berhan referral hospital, 
2017. 
Name of principal investigator – Ketemaw Zewdu 
Name of organization- University of Gondar, Gondar College of Medicine 
and Health Sciences, School of medicine, Department of Optometry 
Name of sponsor - Amhara National Regional State health bureau  
Introduction 
This information sheet and consent form was prepared with the aim of studying 
the prevalence and associated factors of visual impairment among diabetic 
patients at Debre Berhan Referral Hospital, 2017. The research group included 
the principal investigator, six trained data collectors and two advisors from 
University of Gondar.  
Purpose of the research project 
The main purpose of this study was to assess the prevalence and associated 
factors of visual impairment among diabetic patients at Debre Berhan referral 
hospital. 
Procedures  
The study involved diabetic patients who were 18 years old and above from 
April 27 to may 19, 2017. All diabetic patients at Debre Berhan referral 
hospital and who consented to participate were included to the study. 
Questions regarding socio-demography, knowledge about the effect of DM on 
the eye, behavioral factors and clinical conditions were asked or taken from 
the patients' folder. The vision of the patients was checked and anterior and 
posterior segment examinations were done. 
Benefits, Risks and/of Discomfort  
By participating in this research project, it may waste some of your time (a 
maximum of 25 minutes). However your participation is definitely important to 
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assess prevalence of visual impairment and associated factors among diabetic 
patients in Debre Berhan referral hospital. It is also important to design 
appropriate strategy for the avoidance of these vision impairing conditions. 
There is no risk in participating in this research project. Your benefit is free and 
full ocular examination.  
 Incentives/Payments for Participating 
You will not be provided any incentives or payments to take part in this project. 
Confidentiality 
Your name  will not be written and the information collected from you will be kept 
confidential and stored in a file, by giving a code. Hence, no report of the study will 
ever identify you. 
Right to Refusal or Withdraw 
You have full right to refuse from participating in this research and to  withdraw at 
any time you wish.  
Person to contact  
This research project was reviewed and approved by the ethical committee of the University 
of Gondar. If you have any question you can contact any of the following individuals and you 
may ask at any time you want. 
    Name: Ketemaw Zewdu     Name: Nebiyat Fleke   Name: Destaye Shiferaw     
        Tele: 0918150629          Tele: 0918035619        Tele:   0918032216            
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Annex 2 Informed Consent Form (English Version) 
Name of the participant --------------------------- ID-------------------- 
 
 Consent form for interview and eye examination to asses visual 
impairment and associated factors in DM patients. 
 Dear sir/madam  
You are selected to participate in a study on the prevalence and associated factors 
of visual impairment among diabetic patients at DBRH. It will take a maximum of 25 
minutes. The data obtained from you will be collected for research purpose. It will 
indirectly contribute in bringing solutions to avoid visual impairment in diabetic 
patients.  
With your permission, we would like to conduct some interviews and examine your 
eyes. Your participation is voluntary and you have the right to refuse the participation 
or withdraw your consent at any time. All the information we collect will be 
confidential and no identifiable information will be released. Your response will never 
be exposed to anyone.  
Would you like to participate in the study?   
Yes...............                                        No.......... 
I understand this consent and the purpose of the study have been explained 
to me by a language I can understand. I am voluntary to participate in the 
study.  
Participant-----------------------------------sign---------date------------------------
Researcher/witness ---------------------- sign---------  date ------------------------- 
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Annex 3 Informed Consent (Amharic Version) 
የተከበሩ አቶ/ወይዘሮ/ወይዘሪት __________ 
በደብረ ብርሃን ሪፈራል ሆስፒታል የስኳር ሕመም ታካሚዎች የእይታ ችግር/እክል ላይ በሚደረገው ጥናት ይሳተፉ 
ዘንድ ተመርጠዋል፡፡ ከእርስዎ የምናገኘው መረጃ ለጥናትና ምርምር ጥቅም የሚውል ሲሆን ይህም ለወደፊት በስኳር 
ሕመምተኞች ላይ ያለውን የእይታ ችግር ለማስወገድ ለሚደረገው ዕቅድ እንደ ግብዐት ያገለግላል፡፡ ፈቃደኛ ከሆኑ 
አንዳንድ ጥያቄዎችን ጠይቀን ዓይንዎትን እንመረምርዎታለን፡፡ በዚህ ጥናት ላይ የሚያደርጉት ተሳተፎ በእርስዎ ፈቃድ 
የተመሰረተ ሲሆን ተሳተፎውን መቀጠል ካልፈለጉ በማንኛውም ሠዓት ማቋረጥ ይችላሉ፡፡ ከእርስዎ የሚወሰድ 
ማንኛውም መረጃ በሚስጥር የተጠበቀ ሲሆን በጥናቱ ላይም የእርስዎን ማንነት የሚገልጽ ነገር አይገለጽም፡፡  
ጥናቱን መሳተፍ ይፈልጋሉ?  1) አዎ           2) አልፈልግም 
 
የጥናቱ ዓላማና ጥቅም በሚገባኝ ቋንቋ ተገልጾልኝና ተረድቼ በጥናቱ ለመሳተፍ ፈቃደኛ ነኝ፡፡  
የተሳታፊው ስም __________ፊርማ __________ቀን __________ 
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Annex 4 English version of questionnaire  
Pre tested and semi structured questioners with data extraction form for prevalence 
and associated factors of visual impairment among diabetic patients in DBRH, North 
Shoa,  Ethiopia. 
 Introduction   
Good morning/afternoon, my name is --------------------------------. I am a member of a 
research group which studies the prevalence and associated factors of visual 
impairment among diabetic patients in Debre Berhan referral hospital. You are kindly 
invited be one of the study participants in our project. Your truth full answers for all of 
our questions and good cooperation during the examination are very important to 
determine the prevalence and associated factors of visual impairment among 
diabetic patients. Your answers will be confidential and secret. It is your right not to 
participate in the study, stop at any time or skip any question you do not want to 
answer. But we appreciate that if you  participate.  
Thank you.  
Next, I will read a consent, which assures your interest to participate. 
Do I have your permission to continue? 
If yes thank you and continue -------------- 
If no, thank you and go to next study subject -------------- 
                                     Data collector  
 
Name ----------------------- signature ------------------------ date ------------------- 
                     
                                       Checked by supervisor 
 
Name --------------------- signature---------------------- date-------------------  
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Part 1. Socio-demographic data 
1. ID  __________ 
2. Age (year) ___________ 
3. Sex  1) Male  2) Female 
4. Religion  1) Orthodox  2)Muslim  3)Protestant  
 4) Catholic   5) Other Specify______ 
5. Ethnicity 1) Amhara  2) Oromo  3)Afar  4)Tigrie 
   5) Other specify_______ 
6. Marital status  1) Single 2) Married 3) Widowed 4) Divorced 
7. Educational status 1) cannot read and write 2) Can read and write 
only 3) primary school 4) Secondary school 5) College/University  
8. Occupation 1) daily laborer 2) merchant 3) employed 4) farmer
 5) house wife 6) retired 7) not employed 8) Other specify 
9. Residence  1) Urban        2) Rural 
10. Monthly income __________ETB 
Part 2. Data on behavioral factors 
11. Do you drink alcohol? if no go to question 21. 1) Yes         2)  No 
12.  How frequent?___________ How many units?_________ 
13. Do you do physical exercises ? if no go to question 25. 1) Yes      2)  No 
14. How frequent?___________ How long?_________ 
15. Have you been examined your eye before? if no go to question 27. 
  1)Yes      2)No  
16. When?  1) within 1 week  2) 1week -1 month 3) 1 month - 6 months
 4) 6 months- one year 5) before one year  6) I don't remember 
Part 3. Clinical data 
17. BMI __________height(m) __________weight(kg)__________ 
18. Type of DM 1) Type 1            2) Type 2 
19. Duration of DM since diagnosis? __________Years 
20.  Level of recent fasting blood sugar? __________mg/dl 
21. Mode of treatment?  1) tablets  2) injections  3) diet 
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22. Are there any visual symptoms you know?  1) Yes         2)  No 
Part 4. Data on systemic co-morbidities 
23. HPN?  1) Yes         2)  No 
24. HIV?  1) Positive        2)  Negative  3) I don't know 
Part 5. Data on ocular examination 
 Right eye Left eye 
25.  Distance 
PVA 
  
26.  PH   
27.  Ocular 
abnormalities 
1. Normal  
2. Cataract  
3. RE  
4. DR  
5. Glaucoma  
6. Others specify---------- 
1. Normal  
2. Cataract  
3. RE  
4. DR  
5. Glaucoma  
6. Others specify------ 
 
Thank you! 
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Annex 5  Amharic version of questionnaire 
የአማርኛ መጠይቅ ቅጽ 
ጤና ይስጥልኝ እኔ ………………………………………እባላለሁ፡፡  የመጣሁት ከጎንደር ዩኒቨርስቲ ነዉ፡፡  
በደብረ ብርሃን ሪፈራል ሆስፒታል የስኳር ሕመም ታካሚዎች የእይታ ችግር/እክል እና ተዛማጅ ምክንያቶች ዙሪያ 
የዳሰሳ ጥናት አባል ነኝ፡፡ እርስዎ ጥናቱን ይሳተፉ ዘንድ በአክብሮት እንጠይቃለን፡፡ በእይታ እክል/ችግር እና ተዛማጅ 
ምክንያቶች በተመለከተ ለምንጠይቅዎት ጥያቄወች የሚሰጡን ትክክለኛ መልስ እና ዓይንዎትን በምንመረምርበት ወቅት 
የሚያደርጉልን ትብብር ለጥናቱ በጣም ጠቃሚ ድርሻ አለው፡፡ ከእርስዎ የሚወሰድ ማንኛውም መረጃ በሚስጥር 
የተጠበቀ ነው፡፡ በጥናቱ ላይ አሁንም ሆነ መሀል ላይ መሳተፍ ባይፈልጉ ተሳትፎውን ማቋረጥ መብትዎ ነዉ፡፡ ነገር ግን 
ጥናቱ ከሚሰጠዉ ጥቅም አንጸር ቢሳተፉ ደስ ይለናል፡፡ መጠይቁን ለማጠናቀቅ ቢበዛ 25 ደቂቃ ይወስዳል፡፡  
ጥናቱን መሳተፍ ይፈልጋሉ?   
አመሰግናለሁ፤ከዚህ በመቀጠል ለመሳተፍ ፈቃደኝነትዎን የማረጋገጫ ጽሑፍ አነብለዎታለሁ፡፡ 
ለመቀጠል ይስማማሉ? 
ከተስማሙ አመሰግናለሁ፡፡ መጠይቁ ይቀጥላል፡፡ 
ካልተስማሙም አመስግነህ  ቀጣዩን ተሳታፊ ጠይቅ፡፡ 
          መረጃ ሰብሳቢ  
ስም…………………………………………………………..    
ፊርማ………………………………. ቀን………………………..   
            ያረጋገጠዉ ተቆጣጣሪ   
ስም…………………………………………………………….     
ፊርማ…………………………..  ቀን………………………… 
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ክፍል 1.  ማህበራዊ እና ስነ ህዝባዊ መረጃ 
1. መለያ ቁጥር __________  
2. እድሜ በዓመት ___________ 
3. ጾታ      1) ወንድ                2) ሴት  
4. ሃይማኖት  1) ኦርቶዶክስ    2) ሙስሊም   3) ፕሮቲስታነት   
  4) ካቶሊክ    5) ሌላ ይጥቀሱ 
5. ብሔር    1) አማራ  2) ኦሮሞ  3)አፋር   4)ትግሬ  5) ሌላ ይጥቀሱ 
6. የጋበቻ ሁኔታ   1) ያላገባ/ች  2) ያገባ/ች  3) የሞተበት/ባት   4) የፈታ/ች 
7. የትምህርት ደረጃ  1) ማንበብና መጻፍ የማይችል     2) ማንበብና መጻፍ ብቻ የሚችል    
      3) አንደኛ ደረጃ     4) ሁለተኛ ደረጃ           5) ኮሌጅ/ዩኒቨርስቲ  
8. ሥራ  1) የቀን ሠራተኛ  2) ነጋዴ  3) ተቀጠሮ የሚሰራ/የምትሰራ  4) አርሶ 
አደር   5) የቤት እመቤት  6) ጡረታ  7) ሥራ የሌለው/ላት 8) ሌላ ይጥቀሱ 
9. መኖሪያ ቦታ   1) ከተማ         2) ገጠር  
10. ወርሃዊ ገቢ  ብር __________ 
ክፍል 2.  
11. አልኮል ይጠጣሉ ? (መልሱ የለም ከሆነ ወደ ጥያቄ 21 ይለፉ)  1)አዎ        2)የለም 
12.  በየ ሥንት ጊዜው ይጠጣሉ__________ ምን ያክል ይጠጣሉ?  __________ 
13. የአካል ብቃት እንቅስቃሴ ያደርጋሉ? (መልሱ የለም ከሆነ ወደ ጥያቄ 25 ይለፉ) 1)አዎ       
2)የለም 
14.  በየ ሥንት ጊዜውይሰራሉ__________ ምን ያክል ደቂቃ ይሰራሉ?  __________ 
15. ከዚህ በፊት ዓይንዎትን ተመርምረው ያውቃሉ? (መልሱ የለም ከሆነ ወደ ጥያቄ 27 ይለፉ)  
  1) አዎ               2) የለም 
16. ዓይንዎትን መቼ ነበር የተመረመሩት?  1) ከ1 ሳምንት ወዲህ  2) ከ1 ሳምንት -1 ወር ወዲህ 
3) ከ1 ወር -6 ወር   4) ከ6 ወር -1 ዓመት ወዲህ  5) ከ 1 ዓመት በፊት  6) 
አላሰታውስም 
17. ክፍል 3. የሕክምና ምርመራን የተመለከተ መረጃ  
18. BMI __________ ቁመት በሜ. __________ ክብደት በኪ.ግ. __________ 
19. የስኳር ሕመም ዓይነት ዓይነት   1)  ዓይነት  1         2) ዓይነት  2 
20. ስኳሩ ካወቁ ምን ያክል ጊዜ ሆነው?  __________ዓመት  
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21. የስኳሩ መጠን ስንት ነው?(FBS) __________ Mg/dl 
22. የሚወስዱት የመድኃኒት ዓይነት?  1. የሚዋጥ   2. በመረፌ የሚወጋ 3. አመጋገብ  
23. እርስዎ የሚያውቁት የእይታ ችግር አለ?       1)አለ            2)የለም 
ክፍል 5. አጠቃላይ ጤንነትን የተመለከተ መረጃ  
24. የደም ግፊት አለበዎት ? 1) አለ            2)የለም 
25. ኤቸ አይ ቪ ?  1) አለ            2)የለም    3) አላውቅም 
ክፍል 5. የዓይን ምርመራን የተመለከተ መረጃ  
  Right eye Left eye 
26.  Distance 
PVA 
   
27.  PH   
28.  Ocular 
abnormalities 
1) Normal  
2) Cataract  
3) RE  
4) DR  
5) Glaucoma  
6) others specify------ 
1) Normal  
2) Cataract  
3) RE  
4) DR  
5) Glaucoma  
6) others specify------  
 
እናመሰግናለን! 
 
 
 
 
 
 
 
 
 
40 
 
 
 
Annex 6 Declaration 
I, the undersigned, senior clinical optometry student declare that this thesis result is 
my original work in partial fulfillment of the requirements for the Masters degree in 
Clinical Optometry.  
Name:   Ketemaw Zewdu  
Signature: ------------------- 
Place of submission: University of Gondar, College of Medicine and Health 
Sciences, Department of Optometry 
Date of Submission: ------------------------ 
This thesis report work has been submitted for ethical review with my/our 
approval as university advisor(s). 
Advisors  
                Name                                               Signature                       Date 
 
 1. Mr. Nebiyat Feleke                    ------------------             --------------               
                 2. Mr. Destaye Shiferaw                ------------------            -------------- 
 
 
 
 
 
 
 
 
 
 
41 
 
 
Annex 7 Assurance Of Investigator 
I, the undersigned agrees to accept responsibility for the scientific, ethical and 
technical conduct of the research project and for provision of required progress 
reports as pre terms and conditions of the research and publications office of the 
University of Gondar. 
Name of the student: Ketemaw Zewdu 
2.  
Date: ----------------------- Signature: ------------------------------ 
 
Approval of the advisor (s)  
Advisors  
                Name                                               Signature                       Date 
 
 1. Mr. Nebiyat Feleke                    ------------------             --------------               
                 2. Mr. Destaye Shiferaw                ------------------            -------------- 
 
 
 
              
 
 
 
 
 
 
 
 
 
 
